Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
89 hedge funds and large institutions have $543M invested in Epizyme, Inc in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 27 reducing their positions, and 20 closing their positions.
107% more call options, than puts
Call options by funds: $93K | Put options by funds: $45K
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
17% more capital invested
Capital invested by funds: $465M → $543M (+$78.2M)
0% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 27
9% less funds holding
Funds holding: 98 → 89 (-9)
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$9.49M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$8.08M |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
+$2.52M |
| 4 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
+$2.22M |
| 5 |
OPPM
Opus Point Partners Management
New York
|
+$1.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$11.8M |
| 2 |
Primecap Management
Pasadena,
California
|
-$11.8M |
| 3 |
State Street
Boston,
Massachusetts
|
-$11.2M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.39M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$3.3M |
EPZM Hedge Fund Activity: Q4 2015 in Review
89 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2015, worth a combined $543M — up 17% from $465M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of EPZM and 11 opened new positions — a net loss of 9 holders — while 27 trimmed existing stakes and 27 added.
The largest buyer was Jennison Associates, adding an estimated $9.49M. The largest seller was EcoR1 Capital, cutting an estimated $11.8M.
- 89 institutional investors held Epizyme, Inc (EPZM) as of Q4 2015, down from 98 in Q3 2015.
- Funds reported $543M of Epizyme, Inc stock for Q4 2015, up 17% quarter-over-quarter.
- 11 funds opened new Epizyme, Inc positions in Q4 2015 and 20 closed out, a net change of -9 holders.
- The largest Epizyme, Inc buyer in Q4 2015 was Jennison Associates, an estimated $9.49M added.
- The largest Epizyme, Inc seller in Q4 2015 was EcoR1 Capital, an estimated $11.8M sold.
Based on aggregated 13F filings for Q4 2015.